NYXH

NYXH

USD

Nyxoah SA Ordinary Shares

$6.100+0.080 (1.329%)

السعر في الوقت الحقيقي

Healthcare
Medical Instruments & Supplies
بلجيكا

مخطط الأسعار

Loading Chart...

المقاييس الرئيسية

مقاييس السوق
أساسيات الشركة
إحصاءات التداول

مقاييس السوق

الافتتاح

$6.020

الأعلى

$6.200

الأدنى

$6.012

الحجم

0.01M

أساسيات الشركة

القيمة السوقية

230.2M

الصناعة

Medical Instruments & Supplies

البلد

Belgium

إحصاءات التداول

متوسط الحجم

0.13M

البورصة

NGM

العملة

USD

نطاق 52 أسبوعاً

الأدنى $5.55الحالي $6.100الأعلى $12.21

أخبار ذات صلة

PR Newswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH

Pomerantz LLP is investigating claims on behalf of investors of Nyxoah S.A. ("Nyxoah" or the "Company") (NASDAQ: NYXH). Such investors are advised to ...

عرض المزيد
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH
PR Newswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH

Pomerantz LLP is investigating claims on behalf of investors of Nyxoah S.A. ("Nyxoah" or the "Company") (NASDAQ: NYXH). Such investors are advised to ...

عرض المزيد
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH
Analyst Upgrades

Stifel Maintains Buy on Nyxoah, Lowers Price Target to $14

Stifel analyst Jonathan Block maintains Nyxoah with a Buy and lowers the price target from $15 to $14.

عرض المزيد
Stifel Maintains Buy on Nyxoah, Lowers Price Target to $14
GlobeNewswire

Conditional Issuance of Shares

INSIDE INFORMATIONREGULATED INFORMATION Conditional Issuance of Shares Mont-Saint-Guibert, Belgium – April 16, 2025, 8:00 am CET / 2:00 am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) ("Nyxoah" or the "Company"),

عرض المزيد
Conditional Issuance of Shares
PR Newswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH

Pomerantz LLP is investigating claims on behalf of investors of Nyxoah S.A. ("Nyxoah" or the "Company") (NASDAQ: NYXH). Such investors are advised to ...

عرض المزيد
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH
Analyst Upgrades

HC Wainwright & Co. Reiterates Buy on Nyxoah, Maintains $15 Price Target

HC Wainwright & Co. analyst Edward White reiterates Nyxoah with a Buy and maintains $15 price target.

GlobeNewswire

Nyxoah Provides Update on FDA Approvable Letter for Genio System

Nyxoah Provides Update on FDA Approvable Letter for Genio System Expects to meet final FDA requirements for full PMA approval in the second quarter Mont-Saint-Guibert, Belgium – April 8, 2025, 07:00am CET / 1:00am ET –

ابق على اطلاع

تعيين تنبيهات الأسعار، الحصول على تحديثات تحليل الذكاء الاصطناعي وأخبار السوق في الوقت الحقيقي.